Xcout Intel
TILT Biotherapeutics competitors & alternatives
The 12 closest competitors and alternatives to TILT Biotherapeutics among biotech companies — ranked by similarity to what TILT Biotherapeutics actually does, not by market-cap band.
Subscribe to see TILT Biotherapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About TILT Biotherapeutics
TILT Biotherapeutics is a Finnish biotechnology company developing tumor-targeted immunotherapies, including oncolytic adenoviruses designed to stimulate immune responses against solid tumors. Its therapies are intended for cancer patients and are developed through clinical and pharmaceutical partnerships.
TILT Biotherapeutics at a glance
TILT Biotherapeutics is a biotech company headquartered in Finland. Xcout tracks 12 named people at TILT Biotherapeutics, including Aino Kalervo (Chief Executive Officer).
TILT Biotherapeutics leadership
- Aino KalervoChief Executive Officer
- Suvi SorsaChief Operating Officer
- Gianfranco PittariChief Medical Officer
- Arto LinnervuoChairman of the Board of Directors, Legal Advisor
- Akseli HemminkiFounder & CEO and Member of the Board of Directors
- Hanna KirkVP Product Development
6 more named people on record for TILT Biotherapeutics, with roles, board committees and tenure — see the full roster →
Top 12 TILT Biotherapeutics competitors
Ranked by semantic similarity — how close each company is to TILT Biotherapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
CVBio is a biotechnology company that develops virus-driven immunotherapies, specifically utilizing engineered oncolytic adenoviruses to target and destroy resistant cancer cells. The company's platform is designed to treat aggressive cancers, including adult and pediatric brain tumors, by selectively infecting tumor cells and eliciting an anti-tumor immune response.
Biotechnology
T3 Pharmaceuticals AG is a biotechnology company that develops a proprietary technology platform utilizing bacteria to deliver targeted therapies. The company focuses on advancing a pipeline of Immuno-Oncology products designed to treat cancer patients.
Similar biotech company
Lytix Biopharma is a clinical-stage biotechnology company developing oncolytic molecule therapies to treat superficial and deep-seated tumors. The company focuses on the neoadjuvant setting, providing first-in-class immunotherapies designed to destroy cancer cell membranes and stimulate a broad immune response.
Similar biotech company
Zelluna is a Norwegian biotechnology company developing T-cell receptor (TCR)-based natural killer (NK) cell therapies for cancer, with a focus on treating solid tumors. Its products are intended for oncology patients, particularly those with cancers that are difficult to treat using existing immunotherapies.
Similar biotech company
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Similar biotech company
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel T cell receptor engineered T cell therapies to fight cancer. The company is involved in biotechnology research and has a presence in Berlin, Germany.
Similar biotech company
Immatics is a biopharmaceutical company that develops T cell-based immunotherapies and bispecific product candidates to treat various types of cancer. The company focuses on precision targeting of the PRAME protein expressed in multiple solid tumors, serving cancer patients with high unmet medical needs.
Biotechnology
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Biotechnology
Founded in 2018 and headquartered in San Diego, IconOVir Bio, Inc. is a preclinical-stage biotechnology company that specializes in creating therapies to target cancer cells using engineered viruses.
Biotechnology
Affimed Therapeutics is a biotechnology company focused on developing cancer immunotherapies that recruit and activate innate immune cells, particularly natural killer (NK) cells, to attack tumor cells. Its investigational products are intended for oncology patients and are developed for use by cancer-care providers.
Biotechnology
OverT Bio, Inc. is a New York-based biotechnology company that pioneers next-generation cellular therapies and biologics at scale. The company focuses on developing effective and safe cellular treatments for solid tumors.
Biotechnology
Immunicum AB is a Swedish biotechnology company that developed allogeneic cell-based cancer immunotherapies, including the investigational product ilixadencel. Its programs were aimed at stimulating patients’ immune systems to treat solid tumors, serving oncology patients and healthcare providers.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of TILT Biotherapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for TILT Biotherapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →